Rock Health Gathers Healthcare & Technology Stars: A Photo Gallery

1/11/12Follow @soonishpodcast

In short order, startup incubator Rock Health has become one of the Bay Area’s hubs for entrepreneurs working on technology ideas that could change healthcare delivery.

Formed last year to test whether the startup accelerator model pioneered by organizations like Y Combinator and TechStars will work in the healthcare industry, Rock Health has already graduated its first class of 13 startups and assembled a high-powered group of entrepreneurs, investors, and other advisors to mentor the early-stage companies in its network. (A second group of startups enters the program this month.)

Rock Health drew on this community to fill a banquet hall at Farallon in downtown San Francisco this Sunday, on the cusp of the annual JP Morgan Healthcare conference, which draws much the leadership of the U.S. biotech and pharmaceutical communities. Loosely designed to recognize the 50 leading influencers in digital health, the dinner also served as a prime networking opportunity—and, for some entrepreneurs, a chance to show off their wares. AliveCor chief medical officer David Albert, for example, gave live demonstrations the company’s portable cardiac monitor, which is built into an iPhone case (see the third image in our slide show below).

“We organized the event to recognize and celebrate the leaders making things happen in digital health,” says Leslie Ziegler, creative director at Rock Health. “We hope the format of the evening allowed these diverse minds to talk freely about the future of the space, meet and support newcomers, and find new ways to collaborate.”

San Francisco-based photographer Toni Gauthier was on hand to document the event, and Rock Health has shared some of the resulting images with Xconomy, which was a media sponsor of the event. The dinner’s main supporters were Rock Health partners Silicon Valley Bank and Fenwick & West.

L to R: Michael Esquivel (Fenwick & West), Leslie Ziegler (Rock Health), Jackson Wilkinson (WeSprout).

Photo by Toni Gauthier

Wade Roush is the producer and host of the podcast Soonish and a contributing editor at Xconomy. Follow @soonishpodcast

Currently on Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
  • It’s too bad there’s a glut of consumer mHealth out there right now, same can be said for CES. We have a ton of “me too’s” so again the incubator folks would do well to incubate with themselves and create apps that do more than one thing. Problem is that the consumer is very slow to adapt and see value as everything wants the consumer to give time but little value has been proven yet.

    Now if you want value and a vehicle, get those bar codes out on FDA recalls and they you would see more of a consumer interest. I have been blogging about this same topic for a few years and wrote an EMR a few years ago myself and it’s the same old stuff and marketing today really puts a spin on it with math no longer being 100% methodology for measuring accuracy.

    It’s all about more algorithms to sell more software which in itself i not bad but so much glut and lack of consumer participation and we don’t have any role models either. I can’t even find so much as a picture of HHS Sebeluis on the web with as much as a cell phone in her hand:) Bar codes for FDA recalls would have value and engage consumers and in addition we all worry about who gathers and sells data.

    Actually every time a buy a tire for my car I think about the billions made with selling data as Walgreens said their data selling business is worth just under $800 million, data they get for free and some states have had to install software to keep the data mining bots out as the servers slow down to a crawl and consumers can’t get in and this is what it was set up for.

    Most consumer apps today are built around advertising and selling data too so I say license and tax those folks, like a sales tax for what they get to sell “free taxpayer data” they mine. It will all choke out one day here.

    So again based on these side effects I too don’t have a lot of interest as I know when I read the fine print it’s all about making money selling algorithms, whether the data is correct or flawed. There’s plenty of good but with the current economy today, it’s the Attack of the Killer Algorithms to watch for with flawed data and hopefully our new Consumer Financial Chief will have a “tiny” bit of IT in his background. If not, we are screwed as corporate US knows how work it and with machine learning data we are somewhat writing the unreadable too, words credited from Kevin Slavin.